NDC 63323-012
Oxytocin
Oxytocin
Oxytocin is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Oxytocin.
| Product ID | 63323-012_1ea6fccc-d789-4560-a50e-a89f2126d7e5 |
| NDC | 63323-012 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Oxytocin |
| Generic Name | Oxytocin |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2000-08-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018248 |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | OXYTOCIN |
| Active Ingredient Strength | 10 [USP'U]/mL |
| Pharm Classes | Increased Uterine Smooth Muscle Contraction or Tone [PE],Oxytocic [EPC],Oxytocin [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 63323-012-07
25 VIAL in 1 TRAY (63323-012-07) > 1 mL in 1 VIAL (63323-012-17)
| Marketing Start Date | 2019-11-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 63323-012-11 [63323001211]
Oxytocin INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA018248 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-08-10 |
NDC 63323-012-03 [63323001203]
Oxytocin INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA018248 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-06-14 |
NDC 63323-012-06 [63323001206]
Oxytocin INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA018248 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-06-14 |
NDC 63323-012-00 [63323001200]
Oxytocin INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA018248 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-06-14 |
NDC 63323-012-10 [63323001210]
Oxytocin INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA018248 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-08-10 |
NDC 63323-012-12 [63323001212]
Oxytocin INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA018248 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-08-10 |
NDC 63323-012-17 [63323001217]
Oxytocin INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA018248 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2020-02-05 |
NDC 63323-012-01 [63323001201]
Oxytocin INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA018248 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-08-10 |
NDC 63323-012-21 [63323001221]
Oxytocin INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA018248 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-03-04 |
NDC 63323-012-07 [63323001207]
Oxytocin INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA018248 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-11-08 |
NDC 63323-012-02 [63323001202]
Oxytocin INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA018248 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-06-14 |
NDC 63323-012-30 [63323001230]
Oxytocin INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA018248 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-08-10 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| OXYTOCIN | 10 [USP'U]/mL |
OpenFDA Data
| SPL SET ID: | 6d7d1280-f286-4f39-89f3-2b96571810e6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Pharmacological Class
- Increased Uterine Smooth Muscle Contraction or Tone [PE]
- Oxytocic [EPC]
- Oxytocin [CS]
Medicade Reported Pricing
63323012930 ANASTROZOLE 1 MG TABLET
Pricing Unit: EA | Drug Type:
63323012310 METHOTREXATE 250 MG/10 ML VIAL
Pricing Unit: ML | Drug Type:
63323012140 METHOTREXATE 25 MG/ML VIAL
Pricing Unit: ML | Drug Type:
63323012110 METHOTREXATE 25 MG/ML VIAL
Pricing Unit: ML | Drug Type:
63323012104 METHOTREXATE 25 MG/ML VIAL
Pricing Unit: ML | Drug Type:
63323012102 METHOTREXATE 25 MG/ML VIAL
Pricing Unit: ML | Drug Type:
NDC Crossover Matching brand name "Oxytocin" or generic name "Oxytocin"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9742 | Oxytocin | Oxytocin |
| 0143-9743 | Oxytocin | Oxytocin |
| 0641-6114 | Oxytocin | Oxytocin |
| 0641-6115 | Oxytocin | Oxytocin |
| 52533-048 | Oxytocin | Oxytocin |
| 52533-051 | Oxytocin | Oxytocin |
| 52533-054 | Oxytocin | Oxytocin |
| 52533-055 | Oxytocin | Oxytocin |
| 52533-056 | Oxytocin | Oxytocin |
| 52533-105 | Oxytocin | Oxytocin |
| 52533-170 | Oxytocin | Oxytocin |
| 52533-233 | Oxytocin | Oxytocin |
| 52533-234 | Oxytocin | Oxytocin |
| 55154-9356 | Oxytocin | OXYTOCIN |
| 55154-9577 | Oxytocin | OXYTOCIN |
| 55154-9584 | Oxytocin | OXYTOCIN |
| 63323-012 | Oxytocin | OXYTOCIN |
| 42023-116 | Pitocin | oxytocin |
| 42023-130 | Pitocin | oxytocin |
Trademark Results [Oxytocin]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OXYTOCIN 78368996 not registered Dead/Abandoned |
Hirsch, Eric Michael 2004-02-17 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.